# Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA)

> **NCT01778920** · PHASE1 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 48 (actual)

## Conditions studied

- Lung and Pleural Malignancies
- Neoplasms
- Nodules
- Adenocarcinoma

## Interventions

- **DRUG:** EC17 imaging contrast agent

## Key facts

- **NCT ID:** NCT01778920
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2016-04
- **Final completion:** 2016-05
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2016-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01778920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01778920, "Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01778920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*